<?xml version="1.0" encoding="UTF-8"?>
<p>In the 270 
 <italic>μ</italic>g/kg Rolontis group, severe neutropenia was reported in one patient (3%) and lasted 1 day (Table 
 <xref rid="cam41388-tbl-0002" ref-type="table-wrap">2</xref>). In the lowest Rolontis dose group (45 
 <italic>μ</italic>g/kg Rolontis), approximately one‐third of patients in (14 patients, 36%) experienced severe neutropenia that lasted between 1 and 5 days. In the 135 
 <italic>μ</italic>g/kg Rolontis group, seven patients (19%) experienced severe neutropenia, which lasted for 1 to 2 days in six patients (17%) and 7 days in one patient, 3%). In the pegfilgrastim group, five patients (14%) experienced severe neutropenia that lasted for 1–3 days.
</p>
